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E D I TO R I A L
Optimizing resynchronization pacing in the failing systemic right ventricle
Biventricular or cardiac resynchronization pacing therapy (CRT) is now
an established modality to potentially improve clinical outcomes, as
well as delay the need for cardiac transplant among patients with sys-
temic ventricular failure. However, published guidelines for patient
selection do not include the surgical interventions and anatomical vari-
ations, including a systemic right ventricle (RV), seen in the evergrow-
ing number of adult patients with repaired congenital heart defects
(CHDs), including those with repaired transposition of the great arter-
ies (TGAs). In addition, guidelines do not address the issue of pre-
existing pacemakers,which are commonly foundamong thesepatients.
Since these young adults can be expected to develop an early ven-
tricular dysfunction and clinical heart failure, based simply on cardiac
anatomy, and regardless of any coronary issues, it is imperative to
explore therapeutic modalities that address the unique clinical chal-
lenges found in this patient population. AlthoughCRThas been applied
to CHD patients using current recommendations for patient selection,
efficacy andclinical improvement rateshavebeenvariable. Theoverre-
liance on QRSmorphology, as well as ventricular ejection fraction (EF)
as primary markers of CRT efficacy, commonly reported among many
publications, including guidelines, has recently come under scrutiny
and questioned in an era of improved diagnostic imaging to detect
changes in ventricular contractility.1–3
In this issue of Pacing and Clinical Electrophysiology, Moore et al4
present a novel approach to determine the best epicardial lead implant
site among six patients with TGA and previously implanted transve-
nous cardiac rhythm devices, utilizing current mapping techniques
found in most cardiac electrophysiology laboratories. Electroanatomi-
cal mapping (EAM) provides 3-dimensional intracardiac electrical acti-
vation sequences in relation to anatomy in a cardiac chamber of inter-
est. Typically applied during arrhythmia mapping, EAM decreases the
need for fluoroscopy, as well as provides more precise substrate loca-
tion, which is necessary for accurate ablation.5 The hybrid catheteri-
zation laboratory technique employed in this study entails a minimally
invasive surgical approach to right ventricular epicardial lead implant
based on the findings of mapped late activation.7 Once the epicardial
leadwas implanted, the leadwas advanced to join with the established
transvenous lead in the venous left ventricle to finalize the CRT pac-
ing system.Ona follow-up interval from5-13months, clinical improve-
ment, based on the QRS duration as well as echo-derived fractional
area of change (FAC) and New York Heart Association clinical clas-
sification occurred in all patients, with five patients being removed
from transplant consideration and one receiving a transplant a year
later.
Evaluation of systemic RV function poses a unique challenge to clin-
icians. The anatomical shape, as well as difficulties to achieve optimal
visualization during cardiac ultrasound studies, often negates EF as an
effective measurement of contractility. In this study, FAC was used,
which in addition toothernoninvasive techniques, suchas strain, dP/dt,
and tissue Doppler, can be more effective markers of contractility.7
Additionally, the authors astutely report that the activation sequences
are patient variable. This important observation confirms previous
reports that there is no “one best” implant site to optimize paced
contractility.8 In this regard, the simple practice of merely implanting
two ventricular leads, without knowledge of which locations ensure
the optimal response, is an outdated and ineffective approach for pac-
ing lead implant.
In the current era of technological advances, newer methods to
more effectivelymeasuremyocardial contractility need to be explored.
This is especially true considering morbidities associated with CRT
implant. Moore et al introduce an effective combination of EAM with
precise epicardial lead implant to optimize paced contractility in a dif-
ficult clinical situation of patients with systemic RVs and early heart
failure.
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